Bristol-Myers Squibb (NY: BMY )
66.98 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Headline News about Bristol-Myers Squibb
I-Mab and one of its investors, VMS, have filed for a Hong Kong IPO of a SPAC that will raise funds to acquire a life science company. Also, RVAC Medicines completed a Series B funding that brings...
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
April 24, 2022
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...
PBI Recently Installed Its Commercial Scale Nanoemulsion Tech For "Safer, Healthier Foods And Beverages" at Ohio State's Renowned Advanced Food Technology Pilot Plant
April 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following